Eliquis, Orencia sales propel Bristol-Myers to strong second quarter
Go back to Eliquis, Orencia sales propel Bristol-Myers to strong second quarter| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 63.06 -0.54 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.60 | 52 Week High | $77.12 | |||
| Open | $64.08 | 52 Week Low | $49.03 | |||
| Day High | $64.35 | P/E | 40.95 | |||
| Day Low | $62.94 | EPS | $1.54 | |||
| Volume | 5,563,493 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 147.03 +2.12 (1.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.91 | 52 Week High | $65.46 | |||
| Open | $145.74 | 52 Week Low | $47.97 | |||
| Day High | $147.40 | P/E | 100.02 | |||
| Day Low | $145.32 | EPS | $1.47 | |||
| Volume | 3,964,213 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.68 +0.22 (0.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.46 | 52 Week High | $37.39 | |||
| Open | $27.62 | 52 Week Low | $28.25 | |||
| Day High | $27.81 | P/E | 16.78 | |||
| Day Low | $27.55 | EPS | $1.65 | |||
| Volume | 12,989,702 | |||||
